Walvax Biotechnology Market Cap

Walvax Biotechnology has a market cap or net worth of 20.28 billion as of August 14, 2025. Its market cap has increased by 9.07% in one year.

Market Cap

20.28B

Enterprise Value

19.30B

Revenue

2.68B

Ranking

n/a

PE Ratio

153.98

Stock Price

12.71

Market Cap Chart

Since November 12, 2010, Walvax Biotechnology's market cap has increased from 13.63B to 20.28B, an increase of 48.73%. That is a compound annual growth rate of 2.73%.

Market Cap History

Date	Market Cap	% Change
Aug 14, 2025	20.28B	4.97%
Dec 31, 2024	19.32B	-48.62%
Dec 29, 2023	37.60B	-41.50%
Dec 30, 2022	64.27B	-28.12%
Dec 31, 2021	89.42B	50.25%
Dec 31, 2020	59.52B	19.33%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Medicine	407.67B
Shenzhen Mindray Bio-Medical Electronics	283.36B
WuXi AppTec	267.34B
Zhangzhou Pientzehuang Pharmaceutical.,	122.37B
Aier Eye Hospital Group	120.66B
Sichuan Biokin Pharmaceutical	118.80B
Shanghai United Imaging Healthcare	107.16B
Yunnan Baiyao Group Co.,Ltd	99.83B

Market Cap Rankings